These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11566600)

  • 21. Expression of recombinant antibody (single chain antibody fragment) in transgenic plant Nicotiana tabacum cv. Xanthi.
    Dobhal S; Chaudhary VK; Singh A; Pandey D; Kumar A; Agrawal S
    Mol Biol Rep; 2013 Dec; 40(12):7027-37. PubMed ID: 24218164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoplasmic reticulum retention motif fused to recombinant anti-cancer monoclonal antibody (mAb) CO17-1A affects mAb expression and plant stress response.
    Song I; Kang Y; Lee YK; Myung SC; Ko K
    PLoS One; 2018; 13(9):e0198978. PubMed ID: 30248125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody production by molecular farming in plants.
    Fischer R; Hoffmann K; Schillberg S; Emans N
    J Biol Regul Homeost Agents; 2000; 14(2):83-92. PubMed ID: 10841283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secretory IgA antibodies from plants.
    Wycoff KL
    Curr Pharm Des; 2005; 11(19):2429-37. PubMed ID: 16026297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of a tumour-targeting antibody with a human-compatible glycosylation profile in N. benthamiana hairy root cultures.
    Lonoce C; Salem R; Marusic C; Jutras PV; Scaloni A; Salzano AM; Lucretti S; Steinkellner H; Benvenuto E; Donini M
    Biotechnol J; 2016 Sep; 11(9):1209-20. PubMed ID: 27313150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant anti-hCG antibodies retained in the endoplasmic reticulum of transformed plants lack core-xylose and core-alpha(1,3)-fucose residues.
    Sriraman R; Bardor M; Sack M; Vaquero C; Faye L; Fischer R; Finnern R; Lerouge P
    Plant Biotechnol J; 2004 Jul; 2(4):279-87. PubMed ID: 17134389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of hybrid-IgG/IgA plantibodies with neutralizing activity against Shiga toxin 1.
    Nakanishi K; Narimatsu S; Ichikawa S; Tobisawa Y; Kurohane K; Niwa Y; Kobayashi H; Imai Y
    PLoS One; 2013; 8(11):e80712. PubMed ID: 24312238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developments in the production of mucosal antibodies in plants.
    Vasilev N; Smales CM; Schillberg S; Fischer R; Schiermeyer A
    Biotechnol Adv; 2016; 34(2):77-87. PubMed ID: 26626615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of plant N-glycans processing: the future of producing therapeutic protein by transgenic plants.
    Chen M; Liu X; Wang Z; Song J; Qi Q; Wang PG
    Med Res Rev; 2005 May; 25(3):343-60. PubMed ID: 15499575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits.
    Jin C; Altmann F; Strasser R; Mach L; Schähs M; Kunert R; Rademacher T; Glössl J; Steinkellner H
    Glycobiology; 2008 Mar; 18(3):235-41. PubMed ID: 18203810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of mouse monoclonal antibody with galactose-extended sugar chain by suspension cultured tobacco BY2 cells expressing human beta(1,4)-galactosyltransferase.
    Fujiyama K; Furukawa A; Katsura A; Misaki R; Omasa T; Seki T
    Biochem Biophys Res Commun; 2007 Jun; 358(1):85-91. PubMed ID: 17481579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plantibodies in human and animal health: a review.
    Oluwayelu DO; Adebiyi AI
    Afr Health Sci; 2016 Jun; 16(2):640-5. PubMed ID: 27605982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plantibodies: applications, advantages and bottlenecks.
    Stoger E; Sack M; Fischer R; Christou P
    Curr Opin Biotechnol; 2002 Apr; 13(2):161-6. PubMed ID: 11950570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-terminal vacuolar sorting signal at the mouse antibody alters the N-linked glycosylation pattern in suspension-cultured tobacco BY2 cells.
    Misaki R; Sakai Y; Omasa T; Fujiyama K; Seki T
    J Biosci Bioeng; 2011 Nov; 112(5):476-84. PubMed ID: 21802986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plants as bioreactors for the production of vaccine antigens.
    Tiwari S; Verma PC; Singh PK; Tuli R
    Biotechnol Adv; 2009; 27(4):449-67. PubMed ID: 19356740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of scFv antibody production in transgenic plants.
    Fiedler U; Phillips J; Artsaenko O; Conrad U
    Immunotechnology; 1997 Oct; 3(3):205-16. PubMed ID: 9358273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering crops, a deserving venture.
    Lanfranco L
    Riv Biol; 2003; 96(1):31-54. PubMed ID: 12852173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioproduction of human enzymes in transgenic tobacco.
    Cramer CL; Weissenborn DL; Oishi KK; Grabau EA; Bennett S; Ponce E; Grabowski GA; Radin DN
    Ann N Y Acad Sci; 1996 May; 792():62-71. PubMed ID: 8678421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation and assembly of secretory antibodies in plants.
    Ma JK; Hiatt A; Hein M; Vine ND; Wang F; Stabila P; van Dolleweerd C; Mostov K; Lehner T
    Science; 1995 May; 268(5211):716-9. PubMed ID: 7732380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plants as Factories for Human Pharmaceuticals: Applications and Challenges.
    Yao J; Weng Y; Dickey A; Wang KY
    Int J Mol Sci; 2015 Dec; 16(12):28549-65. PubMed ID: 26633378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.